Clinical Trial
Maternal Hyperoxygenation in Congenital Heart Disease
Study Description
“Maternal Hyperoxygenation in Congenital Heart Disease”
A pilot study investigating the safety and feasibility of chronic maternal hyperoxygenation in the setting of fetal congenital heart disease
Location
Methods
Pharmaceutical medication involved
Recruiting patients only
Drug - Maternal Hyperoxygenation
Oxygen via nasal prongs at 4L/min continuously during 2nd and 3rd trimester of pregnancy until birth
Additional Information
Official Study Title
Maternal Hyperoxygenation in Congenital Heart Disease
Clinical Trial ID
NCT03136835
ParticipAid ID
QdJk2e
